Arcturus Therapeutics Holdings Inc.
SEC CIK 1768224 · ARCT · last insider filing 2026-06-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Farrell Peter C | Director | filed 2019 - 2026 |
| Barlow James F | Director | filed 2019 - 2026 |
| Holmes Edward W | Director | filed 2019 - 2026 |
| Marquet Magda | Director | filed 2019 - 2026 |
| Slaoui Moncef | Director | filed 2024 - 2026 |
| Markels John | Director | filed 2022 - 2026 |
| Marantz Jing L. | Director | filed 2021 - 2026 |
| Payne Joseph E | Director · President and CEO | filed 2019 - 2025 |
| Sassine Andy | Director · Chief Financial Officer | filed 2019 - 2025 |
| Ultragenyx Pharmaceutical Inc. | Director | filed 2019 - 2021 |
| Parschauer Karah Herdman | Director | filed 2019 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Mulroy Dennis | Chief Financial Officer | filed 2026 - 2026 |
| Chivukula Pad | Chief Scientific Officer & COO | filed 2020 - 2025 |
| Kurata Lance | Chief Legal Officer | filed 2020 - 2025 |
| Roberts Joseph | Controller | filed 2025 - 2025 |
| Kummerfeld Keith C | See Remarks | filed 2019 - 2023 |
| Hughes Steven George | Chief Development Officer | filed 2020 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.